Stock Chart
TEVA
Type: SELL growth_1yr
Strike: $32
Premium: $2.99
Expiry: Jan 15, 2027
Target: $27
Score: -100
LEAPs are long-term options (1+ year) with less time decay.
Vol: Current volume vs 20-day average
vs SPY: Relative activity vs market
vs QQQ: Relative activity vs tech
Color Guide:
● Red (≥1.5x): High activity
● Yellow (≥1.2x): Above average
● Blue (≤0.7x): Low activity
Interpretation:
• vs SPY > 1: Stock-specific interest
• vs SPY < 1: Stock quiet vs market
Technical Chart
About TEVA - Teva Pharmaceutical Industries Limited American Depositary Shares
Teva Pharmaceutical Industries, based in Israel, is the leading generic drug manufacturer in the world. Teva derives half of its sales from North America and makes up a high-single-digit percentage of the total number of generic prescriptions in the US. It also has a significant presence in Europe, Japan, Russia, and Israel. Besides generics, Teva has a portfolio of innovative medicines and biosimilars in three main therapeutic areas: the central nervous system with Copaxone, Ajovy, and Austedo; respiratory with Qvar …
Key Statistics
More TEVA Analysis
This TEVA stock chart provides comprehensive technical analysis including candlestick patterns, volume profile analysis, and options open interest data. Track TEVA's price movements with trendlines, gamma walls, and key support/resistance levels.